Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

117.56
Delayed Data
As of Aug 28
 +0.74 / +0.63%
Today’s Change
76.55
Today|||52-Week Range
134.49
+8.89%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-10.92% 3 years+29.97%
3 months-5.26% 5 years+26.46%
1 year+20.18% Since inception+17.54%
Data through 08/29/2015

Quote Details

Previous close$116.82
Open day’s range116.39 – 117.80
Net asset value (NAV)117.53 (08/28/2015)
Daily volume98,308
Average volume (3 months)81,965
Data as of 3:59pm ET, 08/28/2015

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+26.46%+26.72%
Expense Gross exp ratio0.35%0.46%
Risk 5 year sharpe ratio1.831.76
Net assets$1.2B$2.2B
Average market cap$6.8B$38.7B
Average P/E31.326.0
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
DEPO Depomed Inc4.22%
ANIP ANI Pharmaceuticals Inc3.54%
CEMP Cempra Inc3.48%
HZNP Horizon Pharma PLC3.22%
TTPH Tetraphase Pharmaceuticals Inc3.18%
CTLT Catalent Inc3.15%
AGN Allergan3.08%
NKTR Nektar Therapeutics3.07%
ZSPH ZS Pharma Inc3.03%
ENDP Endo International PLC3.02%

Partner Offers